| |
| Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol |
| Scholtissen S, Bruyere O, Neuprez A, Severens JL, Herrero-Beaumont G, Rovati L, Hiligsmann M, Reginster JY |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Scholtissen S, Bruyere O, Neuprez A, Severens JL, Herrero-Beaumont G, Rovati L, Hiligsmann M, Reginster JY. Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol. International Journal of Clinical Practice 2010; 64(6): 756-762 Indexing Status Subject indexing assigned by NLM MeSH Acetaminophen /economics /therapeutic use; Anti-Inflammatory Agents /economics /therapeutic use; Cost-Benefit Analysis; Female; Glucosamine /economics /therapeutic use; Humans; Male; Middle Aged; Osteoarthritis, Knee /drug therapy /economics; Quality-Adjusted Life Years; Treatment Outcome AccessionNumber 22010000878 Date bibliographic record published 13/04/2011 |
| |
|
|
